| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.972 | 106 | 3 | 1994 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.970 | 99 | 6 | 1996 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.400 | None | 0.970 | 99 | 0 | 1998 | 2020 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.989 | 95 | 0 | 2002 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.400 | None | 0.945 | 91 | 3 | 1992 | 2019 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.400 | None | 0.989 | 91 | 0 | 2000 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.400 | None | 0.952 | 83 | 3 | 2000 | 2019 | ||||||||
|
cytochrome P450 family 17 subfamily A member 1 | 0.462 | 0.769 | 2.6E-04 |
|
disease | 0.400 | None | 0.910 | 78 | 3 | 1999 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.974 | 78 | 7 | 1998 | 2019 | ||||||||
|
steroid 5 alpha-reductase 2 | 0.564 | 0.615 |
|
disease | 0.400 | None | 0.884 | 69 | 5 | 1995 | 2019 | |||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
disease | 0.400 | None | 0.941 | 68 | 5 | 2001 | 2019 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.400 | None | 0.984 | 61 | 0 | 1993 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.400 | None | 0.984 | 61 | 1 | 1998 | 2020 | ||||||||
|
alpha-methylacyl-CoA racemase | 0.510 | 0.769 | 2.7E-02 |
|
disease | 0.400 | None | 0.966 | 59 | 5 | 2002 | 2020 | ||||||||
|
zinc finger BED-type containing 1 | 0.716 | 0.423 | 3.6E-04 |
|
disease | 0.400 | None | 0.982 | 57 | 0 | 2001 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.400 | None | 0.929 | 56 | 2 | 1994 | 2020 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
disease | 0.400 | None | 0.887 | 53 | 1 | 1998 | 2019 | ||||||||
|
insulin like growth factor binding protein 3 | 0.439 | 0.808 | 0.91 |
|
disease | 0.400 | None | 0.943 | 53 | 1 | 1996 | 2018 | ||||||||
|
MDM2 proto-oncogene | 0.362 | 0.846 | 1.00 |
|
disease | 0.400 | None | 0.925 | 53 | 5 | 1999 | 2019 | ||||||||
|
prostate stem cell antigen | 0.555 | 0.615 | 0.17 |
|
disease | 0.400 | None | 1.000 | 53 | 2 | 1998 | 2020 | ||||||||
|
poly(ADP-ribose) polymerase 1 | 0.389 | 0.923 | 3.3E-04 |
|
disease | 0.400 | None | 1.000 | 52 | 1 | 2003 | 2019 | ||||||||
|
ETS variant transcription factor 1 | 0.631 | 0.385 | 0.94 |
|
disease | 0.400 | None | 0.962 | 52 | 0 | 2005 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.400 | None | 0.900 | 50 | 3 | 1999 | 2020 | ||||||||
|
clusterin | 0.426 | 0.885 | 7.8E-05 |
|
disease | 0.400 | None | 0.978 | 45 | 0 | 2000 | 2019 | ||||||||
|
glutathione S-transferase theta 1 | 0.393 | 0.923 | 1.5E-04 |
|
disease | 0.400 | None | 0.864 | 44 | 0 | 1999 | 2016 |